Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BYFrontiers in cell and developmental biology

Engrailed-1 in eccrine sweat gland development and regeneration: from evolutionary innovation to therapeutic perspectives.

5 affiliations
  1. 1Department of Psychiatry and Clinical Psychology, Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
  2. 2The First School of Clinical Medicine, Hubei University of Medicine, Shiyan, Hubei, China.
  3. 3Department of Burns and Plastic Surgery, The Second Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, China.
  4. 4Department of Wound Repair and Dermatologic Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
  5. 5Department of Burns and Plastic Surgery, Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.

Abstract

Functional regeneration of eccrine sweat glands (ESGs) remains a major unmet need in burns and trauma, where extensive skin loss leads to permanent anhidrosis, life-threatening hyperthermia, and impaired quality of life. Here we synthesize evidence pointing to the homeodomain transcription factor Engrailed-1 (EN1) as a central regulator that coordinates ESG development across four interconnected biological functions: (1) establishing a permissive ventral limb field by repressing the WNT7A-LMX1B dorsalization pathway; (2) executing a binary fate switch that suppresses the hair follicle program while activating a pro-glandular program; (3) functioning as a quantitative rheostat whose expression levels determine ESG density-a mechanism potentiated by primate-specific enhancers such as ECE18; and (4) being required for the establishment of a transient eccrine niche (EDEN) that provides mesenchymal support during gland morphogenesis in mouse models. Drawing on this framework, we propose a tiered pathogenesis-regeneration model (Tiers 1-4) mapping to distinct EN1 failures: Tier 1 (ventral field loss) points to bioengineered glabrous skin substitutes; Tier 2 (lineage specification failure) guides strategies to redirect progenitor fate; Tier 3 (aborted morphogenesis) highlights the need for EDEN-like niche reconstruction; and Tier 4 (compromised adult integrity) suggests approaches to reinforce the mechanical anchor of existing glands through EN1-mediated regulation of epidermal isoform of Bullous Pemphigoid Antigen 1 (BPAG1e), a proposed function inferred from in vitro evidence but untested in vivo. This multi-tiered model offers a conceptual framework for functional ESG restoration while addressing translational gaps between embryonic programs and adult tissue competency-a framework that remains speculative and requires rigorous validation in human tissues, as many mechanisms are supported primarily by mouse studies.

Related

  1. Editorial: Decoding cancer complexity with artificial intelligence and molecular level studies: informatics-driven approaches for therapeutic innovation
    Chandrabose Selvaraj, Krishnendu Bera, Senthilkumar Krishnamoorthi +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  2. Advances and perspectives of next-generation antitumor antibody-based modalities: Structural innovation and target-driven strategies.
    Liangjie Sun, Baixin Xu, Shuhang Wang +1
    Acta pharmaceutica Sinica. BPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCPMC
  3. The importance of integrating evolutionary–developmental perspectives into One Health approaches
    Camryn Kritzell, Mary Ann Ottinger, Molly Albecker
    BiosciencePeer-reviewedLicence not statedFull text2 citedEpidemiology & public healthPMC
  4. The Role of Membranes in Tissue Regeneration Therapy: State of the Art and Future Perspectives
    Raphael Ferreira da Silva, Renata Ribeiro de Castro, Gabriela Warwar Teixeira +5
    ACS OmegaPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossrefEurope PMC
  5. The Wnt signaling networks in higher-grade meningiomas: from molecular pathogenesis to therapeutic innovation.
    Arathy S Kumar, Olli Tynninen, Miikka Korja
    Cancer cell internationalPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCDOAJ
BibTeX
@article{zhang2026engrailed1,
  title = {{Engrailed-1 in eccrine sweat gland development and regeneration: from evolutionary innovation to therapeutic perspectives.}},
  author = {Lei Zhang and Zizhen Zhang and Jiaqi Cheng and Junhong Zhao and Yanyi Xing and Xiang Liu and Lihong Peng and Sixun Wu and Haihong Li},
  journal = {Frontiers in cell and developmental biology},
  year = {2026},
  month = oct,
  doi = {10.3389/fcell.2026.1917336},
  url = {https://europepmc.org/article/MED/42903334},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Engrailed-1 in eccrine sweat gland development and regeneration: from evolutionary innovation to therapeutic perspectives.
AU  - Lei Zhang
AU  - Zizhen Zhang
AU  - Jiaqi Cheng
AU  - Junhong Zhao
AU  - Yanyi Xing
AU  - Xiang Liu
AU  - Lihong Peng
AU  - Sixun Wu
AU  - Haihong Li
PY  - 2026
DA  - 2026/10/01
JO  - Frontiers in cell and developmental biology
DO  - 10.3389/fcell.2026.1917336
UR  - https://europepmc.org/article/MED/42903334
AB  - Functional regeneration of eccrine sweat glands (ESGs) remains a major unmet need in burns and trauma, where extensive skin loss leads to permanent anhidrosis, life-threatening hyperthermia, and impaired quality of life. Here we synthesize evidence pointing to the homeodomain transcription factor Engrailed-1 (EN1) as a central regulator that coordinates ESG development across four interconnected biological functions: (1) establishing a permissive ventral limb field by repressing the WNT7A-LMX1B dorsalization pathway; (2) executing a binary fate switch that suppresses the hair follicle program while activating a pro-glandular program; (3) functioning as a quantitative rheostat whose expression levels determine ESG density-a mechanism potentiated by primate-specific enhancers such as ECE18; and (4) being required for the establishment of a transient eccrine niche (EDEN) that provides mesenchymal support during gland morphogenesis in mouse models. Drawing on this framework, we propose a tiered pathogenesis-regeneration model (Tiers 1-4) mapping to distinct EN1 failures: Tier 1 (ventral field loss) points to bioengineered glabrous skin substitutes; Tier 2 (lineage specification failure) guides strategies to redirect progenitor fate; Tier 3 (aborted morphogenesis) highlights the need for EDEN-like niche reconstruction; and Tier 4 (compromised adult integrity) suggests approaches to reinforce the mechanical anchor of existing glands through EN1-mediated regulation of epidermal isoform of Bullous Pemphigoid Antigen 1 (BPAG1e), a proposed function inferred from in vitro evidence but untested in vivo. This multi-tiered model offers a conceptual framework for functional ESG restoration while addressing translational gaps between embryonic programs and adult tissue competency-a framework that remains speculative and requires rigorous validation in human tissues, as many mechanisms are supported primarily by mouse studies.
SN  - 2296-634X
ER  -